Avidian Wealth Enterprises’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Avidian Wealth Enterprises's BMY Position: Q3 2026 in Review
Avidian Wealth Enterprises increased its Bristol-Myers Squibb (BMY) stake by 28% in Q3 2026, buying an estimated $226K and bringing the position to 16,342 shares worth $1.02M. The position accounts for 0.03% of the portfolio, ranked #329.
Avidian Wealth Enterprises first reported a position in BMY in Q1 2019 and has held it in 31 quarters since. The position peaked at $1.19M in Q2 2022. 2,524 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- Avidian Wealth Enterprises held 16,342 shares of Bristol-Myers Squibb worth $1.02M as of Q3 2026.
- Avidian Wealth Enterprises bought 3,576 Bristol-Myers Squibb shares in Q3 2026, an estimated $226K.
- Bristol-Myers Squibb made up 0.03% of Avidian Wealth Enterprises's portfolio in Q3 2026, its #329 holding.
- Avidian Wealth Enterprises first reported a position in Bristol-Myers Squibb in Q1 2019 and has held it in 31 quarters since.
- Avidian Wealth Enterprises's Bristol-Myers Squibb position peaked at $1.19M in Q2 2022.
- 2,524 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on Avidian Wealth Enterprises's 13F filing for Q3 2026, filed 8 Oct 2026.